Profile
Ofir Moreno worked as a Senior Director-Chemistry at Dendreon Corp.
from 2003 to 2007.
He then worked at MEI Pharma, Inc. from 2010 to 2022, where he held the position of Senior Vice President-Pharmaceutical Sciences from 2019 to 2022.
Moreno holds a doctorate degree from Harvard University and an undergraduate degree from Cornell University.
Former positions of Ofir Moreno
Companies | Position | End |
---|---|---|
MEI PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2019-06-30 |
DENDREON CORPORATION | Corporate Officer/Principal | 2007-10-31 |
Training of Ofir Moreno
Cornell University | Undergraduate Degree |
Harvard University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MEI PHARMA, INC. | Health Technology |
Private companies | 1 |
---|---|
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Ofir Moreno